Skip to main content

Chlorpheniramine News

Vernalis and Tris Pharma Receive FDA Approval for Tuzistra XR (codeine polistirex and chlorpheniramine polistirex)

May 1, 2015 – Vernalis plc and Tris Pharma Inc. today announce that the U.S. Food and Drug Administration (FDA) has approved the New Drug Application (NDA) for Tuzistra XR (codeine polistirex and...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related condition support groups

Urticaria, Hives, Allergic Reactions, Hay Fever, Allergic Rhinitis, Cold Symptoms, Allergies

Chlorpheniramine patient information at Drugs.com